Sarah Smith

Sarah Smith

Expertise: ESG Investing, Electric Vehicle Stocks, Short Squeeze Stocks

Education: BA, Government and Gender, Sexuality and Women’s Studies, The College of William & Mary

Awards & Accomplishments: Top 5% of stock pickers on TipRanks

About Sarah:
Sarah Smith is an experienced editor and writer who works to help retail investors make sense of what’s happening every day on Wall Street, and she’s particularly interested in ESG investing, EV stocks, and the rise of speculative trading activity like short squeezes. She has also written for Kiplinger.com, Smithsonian, and Washington City Paper. Sarah is currently working to become a Chartered Financial Analyst (CFA) and has already earned bachelor’s degrees in Government and Gender, Sexuality and Women’s Studies from the College of William and Mary. Her work for InvestorPlace.com focuses on helping investors understand the causes and impacts of daily stock and crypto market movements, and how a disruption in who invests – and how they invest – transforms the market. Sarah is recognized among the top 5% of stock pickers on TipRanks and has an average return of 50%. She lives in Arlington, Virginia.

Connect with Sarah on LinkedIn.

Recent Articles

What Will the Stock Market Do Today? 3 Big Stories to Watch.

What will the stock market do today? All eyes are on tech stocks in hopes for a rebound, and a Bitcoin rally is also sparking buzz.

Chinese EV Stocks: 2 Big Reasons LI, XPEV and NIO Are Driving Higher

EV stocks like LI stock, XPEV stock and NIO stock are on the move Tuesday as investors eye news of dual listings and promising car sales.

Taco Bell NFT: 11 Things to Know About the Digital Taco Auction

Investors were hungry for Taco Bell NFTs, gobbling up the taco-themed gif offerings just minutes after the Rarible auction launched.

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

What did the stock market do today? Investors celebrated new CDC guidance and cheered on Reddit stocks like GME. Here's what else to know.

GLSI Stock: Why Greenwich LifeSciences Is Skyrocketing Today

GLSI stock is skyrocketing again on Monday after the company appointed Dr. Jaye Thompson to run its Phase 3 clinical trials.